Directorate Change

RNS Number : 4243F
JPMorgan Global Growth & Income PLC
04 November 2022
 

Legal Entity Identifier: 5493007C3I0O5PJKR078

4 November 2022

 

JPMorgan Global Growth & Income plc (the "Company")

Directorate and Board Committees Changes

 

As previously announced in the Company's 2022 Annual Report and Financial Statements, and following the Annual General Meeting of the Company, which was held yesterday, the Company confirms that Gay Collins and James Will have both retired from the Board with effect from 3 November 2022. Jane Lewis has assumed the role of Senior Independent Director following Gay's retirement from the Board.

 

The Board would like to thank Gay for her wise counsel and valuable contribution to the Company during her tenure. The Board would also like to thank James for his invaluable support during the Company's merger with The Scottish Investment Trust plc and his subsequent period on the Board assisting with the integration of the companies.

 

As previously announced in the Company's 2022 Annual Report and Financial Statements, the Board further confirms the separation of the Audit and Management Engagement Committee into two individual committees: An Audit Committee, which continues to be chaired by Sarah Whitney; and, a Management Engagement Committee chaired by James Macpherson.

 

The composition of all the Board committees is as follows:

 

Member

Audit Committee

Nomination Committee

Remuneration Committee

Tristan Hillgarth*

Attends by invitation

Chairman

Member

Mick Brewis

Member

Member

Member

Jane Lewis**

Member

Member

Member

James Macpherson

Member

Member

Member

Neil Rogan

Member

Member

Member

Sarah Whitney

Chair

Member

Chair

 

 

*Board Chairman

**Senior Independent Director

 

 

For further information:

 

JPMorgan Funds Limited

Divya Amin

 

 

020 7742 4000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFSEFILEESEFF
UK 100

Latest directors dealings